Friday 17 September
The Clinical Value of mIDH1 Inhibition in Cholangiocarcinoma
Friday, 08:45 - 10:15
View the satellite invitation
The Role of Biomarkers in Patient Management in Immuno-Oncology
Friday, 10:30 - 11:30
View the satellite invitation
Evolving Treatment Landscapes in HNSCC
Friday, 18:45 - 20:15
View the satellite invitation
Saturday 18 September
Navigating the Current Treatment Landscape in Esophageal Cancer With an Eye Toward the Future
Saturday, 08:45 - 10:15
View the satellite invitation
Implementation of Immunotherapy in the First-Line Treatment of Esophageal, Gastroesophageal Junction, and Gastric Cancers
Saturday, 08:45 - 10:15
View the satellite invitation
Advances in Antibody Drug Conjugates in Solid Tumors: Current Treatments and Emerging Therapies
Saturday, 18:45 - 20:15
View the satellite invitation
Sunday 19 September
Making Precision Medicine a Reality for Patients With Cholangiocarcinoma
Sunday, 18:45 - 20:00
View the satellite invitation
Monday 20 September
Spotlight on Emerging Therapies: Multidisciplinary Discussions (Advanced RCC, HCC and DTC)
Monday, 10:30 - 12:00
View the satellite invitation
Tuesday 21 September
Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors
Tuesday, 10:30 - 12:00
View the satellite invitation
Immuno-Oncology for GI Cancers: A Clinical Lens on Current Data
Tuesday, 17:35 - 19:05
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.
View the complete ESMO Congress 2021 Industry Sponsored Satellite Symposia Programme